Increased alpha-B-crystallin expression in mammary metaplastic carcinomas

Area of Science:

• Oncology
• Pathology
• Biomarker Research

Background:

• Mammary metaplastic carcinoma (MPC) is a rare breast cancer subtype, often posing diagnostic challenges.
• Alpha-B-crystallin (αB-crystallin) expression has been implicated in basal-like and metaplastic carcinomas.

Purpose of the Study:

• To evaluate the diagnostic utility of αB-crystallin in metaplastic carcinoma.
• To compare αB-crystallin expression with conventional basal-like markers in MPC and control neoplasms.

Main Methods:

• Immunohistochemistry was used to assess αB-crystallin and basal-like markers (CK5/6, CK14, p63, c-kit, EGFR) in 33 MPCs, 44 high-grade carcinomas, and 28 mesenchymal neoplasms.
• Statistical analysis was performed to determine sensitivity, specificity, and predictive values.

Main Results:

• αB-crystallin was positive in 68% of MPCs. Conventional markers showed varying positivity rates (CK14: 68%, CK5/6: 43%, p63: 45%, c-kit: 21%, EGFR: 25%).
• Combining αB-crystallin with CK14 improved sensitivity to 84% for MPC detection.
• αB-crystallin expression was significantly lower in conventional high-grade carcinomas (14%) and mesenchymal neoplasms (7%).

Conclusions:

• αB-crystallin demonstrates good diagnostic performance for MPC (68% sensitivity, 88% specificity).
• The combination of αB-crystallin and CK14 enhances diagnostic sensitivity for metaplastic carcinoma.
• αB-crystallin serves as a valuable adjunct marker in the diagnosis of metaplastic carcinoma.